The authors reported that women carrying missense variants of uncertain significance (VUS) in ATM had an elevated risk of CBC contralateral breast cancer, particularly among those who underwent RT (RR = 2.98, 95% CI = 1.31–6.80). The gene discussed is ATM; the disease is breast carcinoma.